Sensex, Nifty to make flat-to-cautious start on GST woes; Aurobindo Pharma, Biocon in focus today

By: |
New Delhi | Updated: December 10, 2015 8:55:29 AM

The BSE Sensex and NSE Nifty are likely to open on a soft-to-cautious note on Thursday tracking SGX Nifty

Sensex, Nifty, Stock market today, L&T, BSE, NSEThe BSE Sensex and NSE Nifty are likely to open on a soft-to-cautious note on Thursday tracking SGX Nifty (Photo: Reuters)

The BSE Sensex and NSE Nifty are likely to open on a soft-to-cautious note on Thursday tracking SGX Nifty, mixed Asian markets amid rising uncertainty over the fate of GST.

At 8.26 am (IST), SGX Nifty was up 10 points, or 0.13 per cent, at 7,656.50.

Asian stocks slipped on Thursday as weak oil prices continued to feed global growth worries, while the euro held solid gains after a policymaker poured cold water on market expectations of more easing by the European Central Bank.

The S&P 500 tracked weaker commodities and lost 0.8 per cent on Wednesday, while the Dow lost 0.4 per cent and the Nasdaq shed 1.5 per cent.

Back home, stock markets tumbled for a sixth straight session on Wednesday as the BSE Sensex plummeted by 274 points while the NSE Nifty cracked below the 7,700-level.

Shares of Biocon and Aurobindo Pharma will remain in focus on Friday. NeoBiocon, a collaboration between Biocon Ltd and BR Shetty led UAE-based Neopharma, has partnered with Novartis Middle East FZE to market diabetes drugs Jalra and Jalra-M in the UAE.

Drug firm Aurobindo Pharma has received final approval from the US health regulator to manufacture and market its oral contraceptive Levonorgestrel tablets.

(With agency inputs)

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.